Universitaetsklinikum Bonn Aoer

Bonn 53127

2 studies enrolling now · 4 studies all time

What they study most

Dravet Syndrome, Esophageal Squamous Cell Carcinoma, Hemophilia A

Studies at this site

• A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome — Recruiting now
• A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01) — Recruiting now
• A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A — Running, not enrolling
• BAX 802 in CHA With Inhibitors — Stopped early